Product Overview
[Drug Name]
Generic Name: Pantoprazole Sodium Enteric-Coated Tablets
Trade Name: TaiMeiNiKe Pantoprazole Sodium Enteric-Coated Tablets 40mg*8 Tablets
Pinyin Full Code: TaiMeiNiKe ZuoTuoLaZuoNaChangRongPian 40mg*8 Tablets
[Main Ingredient]
The main ingredient of this product is pantoprazole sodium.
[Properties]
This product is an enteric-coated tablet, which appears white or off-white after removal of the coating.
[Indications/Main Functions]
Indicated for active peptic ulcers (gastric and duodenal ulcers), reflux esophagitis, and Zollinger-Ellison syndrome.
[Specifications]
40mg*8 tablets
[Dosage and Administration]
Oral administration: 40mg (1 tablet) daily, before meals. The treatment course for duodenal ulcers is usually 2-4 weeks, while the treatment course for gastric ulcers and reflux esophagitis is usually 4-8 weeks.
[Adverse Reactions]
Clinical use may occasionally result in headache, dizziness, insomnia, drowsiness, nausea, abdominal pain, diarrhea and constipation, abdominal distension, rash, and muscle pain.
[Contraindications]
1. Contraindicated in breastfeeding women and women in the first trimester of pregnancy. 2. Contraindicated in patients with allergies to this product.
[Drug Interactions]
Oxtoprazole has minimal interactions with other drugs. Compared with omeprazole, it has a lesser effect on the cytochrome P450 system and does not affect the duration of diazepam action. It has no significant interactions with oral contraceptives, digoxin, warfarin, phenytoin, or theophylline.
[Precautions]
1. This product is an enteric-coated formulation; do not chew it before taking. 2. When gastric ulcers are suspected, cancer should be ruled out first. This is because treatment with this product may alleviate symptoms and delay diagnosis. 3. Use with caution in patients with hepatic or renal impairment. In patients with severe liver disease, the effect of this product may be delayed, and the dosage should be reduced. 4. This product should not be taken concurrently with other antacids or acid suppressants. To prevent excessive acid suppression, high doses and long-term use are not recommended for conditions such as peptic ulcers, except for Zollinger-Ellison syndrome. Please read the package insert carefully and follow your doctor's instructions.
[Pediatric Use]
The efficacy and safety data for this product in children have not been established. It is contraindicated in infants and young children.
[Elderly Use]
The efficacy and safety data for this product in children have not been established. It is contraindicated in infants and young children.
[Overdose]
High doses may cause arrhythmia, elevated transaminases, changes in renal function, and granulocytopenia.
[Pharmacology and Toxicology]
This product inhibits gastric acid secretion by specifically targeting gastric mucosal parietal cells, reducing the activity of H+K+-ATPase in these cells. Compared with omeprazole and lansoprazole, this product has a weaker inhibitory effect on cytochrome P450-dependent enzymes.
